A cautionary note regarding the use of the FDA adverse event reporting system

Authors

Katherine L. Wisner, Departments of Psychiatry and Pediatrics, National Children's Hospital, and Department of Obstetrics and Gynecology, George Washington University, Washington, DC, USA. Kwisner@childrensnational.org.
Krista F. Huybrechts, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine; Department of Epidemiology, Brigham and Women's Hospital, Harvard Medical School; T.H. Chan School of Public Health, Boston, MA, USA.

Document Type

Letter to the Editor

Publication Date

6-30-2025

Journal

Archives of women's mental health

DOI

10.1007/s00737-025-01605-x

APA Citation

Wisner, Katherine L. and Huybrechts, Krista F., "A cautionary note regarding the use of the FDA adverse event reporting system" (2025). GW Authored Works. Paper 7351.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/7351

Department

Psychiatry and Behavioral Sciences